24
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Quality of primary health care in China: challenges and recommendations

      review-article
      , PhD a , b , , , Prof, MD c , d , , , Prof, PhD e , , , Prof, FMedSci g , i , , Prof, PhD l , , Prof, PhD k , , Prof, PhD m , , Prof, MPH n , , PhD a , b , , PhD a , , PhD a , o , , Prof, PhD p , , Prof, MD k , , Prof, PhD f , h , , Prof, FRS q , , Prof, MD a , b , , Prof, MD a , , Prof, MD a , b , , Prof, MD a , r , s , , Prof, MD t , u , , Prof, MSc j , , Prof, MD v , , Prof, MD w , , Prof, MD x , , MB y , z , , Prof, MSc aa , , Prof, MD v , , Prof, MD a , b , *
      Lancet (London, England)
      Elsevier Ltd.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Summary

          China has substantially increased financial investment and introduced favourable policies for strengthening its primary health care system with core responsibilities in preventing and managing chronic diseases such as hypertension and emerging infectious diseases such as coronavirus disease 2019 (COVID-19). However, widespread gaps in the quality of primary health care still exist. In this Review, we aim to identify the causes for this poor quality, and provide policy recommendations. System challenges include: the suboptimal education and training of primary health-care practitioners, a fee-for-service payment system that incentivises testing and treatments over prevention, fragmentation of clinical care and public health service, and insufficient continuity of care throughout the entire health-care system. The following recommendations merit consideration: (1) enhancement of the quality of training for primary health-care physicians, (2) establishment of performance accountability to incentivise high-quality and high-value care; (3) integration of clinical care with the basic public health services, and (4) strengthening of the coordination between primary health-care institutions and hospitals. Additionally, China should consider modernising its primary health-care system through the establishment of a learning health system built on digital data and innovative technologies.

          Related collections

          Most cited references36

          • Record: found
          • Abstract: found
          • Article: not found

          Use and prescription of antibiotics in primary health care settings in China.

          Appropriate antibiotic use is a key strategy to control antibacterial resistance. The first step in achieving this is to identify the major problems in antibiotic prescription in health care facilities, especially in primary health care settings, which is where most patients receive medical care.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Burden of hypertension in China: A nationally representative survey of 174,621 adults.

            Hypertension is a major cause of cardiovascular disease. Periodic nationwide surveys are essential for monitoring secular trend of hypertension and its control in population. We assessed prevalence of hypertension and related awareness, treatment and control rates in Chinese adults in 2013-14.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Overprescribing in China, driven by financial incentives, results in very high use of antibiotics, injections, and corticosteroids.

              In appropriate prescribing is a global problem. It is especially salient in China, where drug sales constitute a major portion of health care providers' incomes, price distortions are rampant, and oversight is lax. However, few data exist on the prevalence of inappropriate prescribing in China. This study, the first of its kind in China, examined 230,800 prescriptions written between 2007 and 2009 by 784 community health institutions in 28 cities across China. The data show substantial overprescribing, including twice as many prescriptions for antibiotics as recommended by the World Health Organization and rates of injection that are three times higher than in similar countries. These findings point to the need to integrate rational prescribing into China's ongoing health care reform.
                Bookmark

                Author and article information

                Contributors
                Journal
                Lancet
                Lancet
                Lancet (London, England)
                Elsevier Ltd.
                0140-6736
                1474-547X
                4 June 2020
                6-12 June 2020
                4 June 2020
                : 395
                : 10239
                : 1802-1812
                Affiliations
                [a ]National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
                [b ]Fuwai Hospital, Chinese Academy of Medical Sciences, Shenzhen, China
                [c ]Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine and the Department of Health Policy and Management, Yale School of Public Health, New Haven, CT, USA
                [d ]Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, CT, USA
                [e ]Department of Global Health and Population, Harvard T H Chan School of Public Health, Boston, MA, USA
                [f ]Department of Biostatistics, Harvard T H Chan School of Public Health, Boston, MA, USA
                [g ]Department of Health Care Policy, Harvard Medical School, Boston, MA, USA
                [h ]Institute of Applied Health Research, University of Birmingham, Birmingham, UK
                [i ]General Practice Development and Research Center, Peking University Health Science Center, Beijing, China
                [j ]School of Oncology, Peking University Health Science Center, Beijing, China
                [k ]School of Public Health, Peking University Health Science Center, Beijing, China
                [l ]Department of Public Health and Primary Care, Center of Family Medicine, Ghent University, Ghent, Belgium
                [m ]Department of Health Policy, London School of Economics and Political Science, Institute of Global Health Innovation, Imperial College London, London, UK
                [n ]Health Commission of Shenzhen Municipality, Shenzhen, China
                [o ]Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK
                [p ]Sun Yat-sen Global Health Institute, Sun Yat-sen University School of Public Health, and Institute of State Governance, Guangzhou, China
                [q ]Nuffield Department of Population Health, University of Oxford, Oxford, UK
                [r ]National Health Foundation, Bangkok, Thailand
                [s ]Xizhuangzi Village Clinic, Jinchang, China
                [t ]Director General Office, WHO Headquarters, Geneva, Switzerland
                [u ]Yaojia Township Primary Care Clinic, Zhengzhou, China
                [v ]Department of General Practice, Zhongshan Hospital of Shanghai Medical College Fudan University, Shanghai, China
                [w ]Sichuan Center for Disease Control and Prevention, Chengdu, China
                [x ]Xiangya School of Public Health, Central South University, Changsha, China
                [y ]Health Commission of Yunnan Province, Kumming, China
                [z ]Jijie Township Primary Care Clinic, Gejiu, China
                [aa ]National Office for Maternal and Child Health Surveillance of China, Department of Obstetrics, West China Second University Hospital, Sichuan University, Chengdu, China
                Author notes
                [* ]Correspondence to: Prof Shengshou Hu, National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China huss@ 123456fuwaihospital.org
                [†]

                Contributed equally

                Article
                S0140-6736(20)30122-7
                10.1016/S0140-6736(20)30122-7
                7272159
                32505251
                67739127-a0ea-4b74-99f5-7f72062c2970
                © 2020 Elsevier Ltd. All rights reserved.

                Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

                History
                Categories
                Article

                Medicine
                Medicine

                Comments

                Comment on this article